Anzeige
Mehr »
Login
Samstag, 04.04.2020 Börsentäglich über 12.000 News von 625 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A12HVG ISIN: US71715X1046 Ticker-Symbol: EFY 
Stuttgart
03.04.20
19:04 Uhr
0,025 Euro
+0,001
+2,08 %
1-Jahres-Chart
PHARMACYTE BIOTECH INC Chart 1 Jahr
5-Tage-Chart
PHARMACYTE BIOTECH INC 5-Tage-Chart

Aktuelle News zur PHARMACYTE Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
26.03.PharmaCyte Biotech CEO Discusses Navigating Testing and IND Submission During COVID-19 Pandemic4
11.02.Will PharmaCyte Biotech's Cell-in-a-Box(R) Technology Be The Game Changer To Effectively Treating Pancreatic Cancer?247PCG Media covers the value that PharmaCyte's Cell-in-a-Box technology can bring to the pancreatic cancer market. Future indications expected to target diabetes and cannabinoid therapy.New York, New...
► Artikel lesen
06.02.PharmaCyte Biotech Exploits Potential Of Its Cell-in-a-Box(R) Technology; Targets Billion Dollar Cancer, Diabetes, and Medicinal Cannabinoid Markets220Soulstring Media Group covers how this emerging biotech can become a potential leader in treating pancreatic cancer and diabetes with its Cell-in-a-Box(R) technologyMiami Beach, Florida--(Newsfile Corp....
► Artikel lesen
PHARMACYTE Aktie jetzt für 4€ handeln
04.02.PharmaCyte Biotech Will Have All the Protection It Needs for Pancreatic Cancer Treatment Upon Marketing Approval3
27.01.PharmaCyte Biotech's Pancreatic Cancer Therapy Passes Critical FDA-Required Tests as Countdown to IND Submission Begins4
21.01.PharmaCyte Biotech, Inc. - 8-K, Current Report3
06.01.PharmaCyte Biotech Set to Reach Three Major Milestones in 20206
11.11.19PharmaCyte Biotech Closer to Submitting IND7
08.11.19PharmaCyte Biotech, Inc. - 8-K, Current Report1
28.10.19PharmaCyte Biotech to Change Future of Treating Diseases with Validation of Encapsulation Technology in Pancreatic ...6
16.10.19PharmaCyte Biotech Closer to Submitting IND with Successful Completion of Clinical Trial Product1
11 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2